Phase 3 study for people with Colorectal Cancer
Recruiting Phase 3
This trial at a glance
Where this trial is running
| Site | City | State or country | Status at this site |
|---|---|---|---|
| Port Macquarie Base Hospital | Port Macquarie | NSW | Recruiting |
| Prince of Wales Hospital Au | Randwick | NSW | Recruiting |
| Calvary Mater Newcastle | Waratah | NSW | Recruiting |
| Westmead Hospital | Westmead | NSW | Recruiting |
| Wollongong Hospital | Wollongong | NSW | Recruiting |
| Gold Coast University Hospital | Southport | QLD | Recruiting |
| Townsville Cancer Centre | Townsville | QLD | Recruiting |
| Princess Alexandra Hospital Australia | Woolloongabba | QLD | Recruiting |
| Icon Cancer Centre Kurralta Park | Kurralta Park | SA | Recruiting |
| Box Hill Hospital | Box Hill | VIC | Recruiting |
| Austin Hospital | Heidelberg | VIC | Recruiting |
| Peter Maccallum Cancer Centre | Melbourne | VIC | Recruiting |
| The Alfred Hospital | Melbourne | VIC | Recruiting |
| The Canberra Hospital | Canberra | Australia | Not yet recruiting |
| Fiona Stanley Hospital | Murdoch | Australia | Recruiting |
voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice
Who can join
The official eligibility criteria
Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.
Inclusion Criteria:
* Stage IV colorectal adenocarcinoma not amenable to curative resection.
* No prior systemic treatment for unresectable or metastatic disease. Participants who received adjuvant or neoadjuvant therapy may enroll if there was no recurrence within 12 months of the end of treatment.
* Measurable disease per RECIST v1.1.
* ECOG performance status of 0 or 1.
* Adequate organ function determined by laboratory results.
Exclusion Criteria:
* MSI-H/dMMR per historical data in the medical record.
* BRAF V600E mutation per historical data in the medical record.
* Untreated and/or progressing CNS metastases.
* History of other malignancy within 2 years.
* Treatment with an anti-PD-(L)1 or other immune checkpoint inhibitor for any indication within the last 3 years.
* Active autoimmune disease that has required systemic treatment in the past 2 years.
* Significant concurrent and/or uncontrolled medical condition.
* History of organ transplant, including allogeneic stem cell transplantation.
Other protocol-defined inclusion/exclusion criteria apply.
Dates on the record
Results, publications and the official record
- No results are posted on the official record yet.
- No publications are listed on the official record yet.
- Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.
Sources and dates
- ClinicalTrials.gov – the record this page reformats
- ClinicalTrials.gov processing date: 9 October 2026.
- This page last checked by Voxsanity: 15 October 2026.
Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.
Not medical advice.
Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.
Letter for your doctor
A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.